# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-23-009529
Filing Date
2023-03-28
Accepted
2023-03-28 16:05:32
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | moonlake424b3.htm | 424B3 | 2226306
2 |  | orgstructureexhibit002a.jpg | GRAPHIC | 299247
3 |  | pipelinea.jpg | GRAPHIC | 83983
4 |  | prospectuscoverimage1a.jpg | GRAPHIC | 23577
5 |  | pso_pasi100dataa.jpg | GRAPHIC | 155009
| Complete submission text file | 0001628280-23-009529.txt |  | 3001276

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262643 | Film No.: 23769509
SIC: 2834 Pharmaceutical Preparations